These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 21916307
21. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination. Kostis JB. Am J Ther; 2010; 17(2):188-96. PubMed ID: 19433970 [Abstract] [Full Text] [Related]
24. [New combination of high dosage sartan and 25 mg HCT. Systolic blood pressure lowered by 21 mmHg]. MMW Fortschr Med; 2004 Apr 08; 146(15):68. PubMed ID: 15373029 [No Abstract] [Full Text] [Related]
25. Single-pill combination of amlodipine and valsartan in the management of hypertension. Flack JM, Hilkert R. Expert Opin Pharmacother; 2009 Aug 08; 10(12):1979-94. PubMed ID: 19606937 [Abstract] [Full Text] [Related]
26. Tribenzor for hypertension. Med Lett Drugs Ther; 2010 Sep 06; 52(1346):70-1. PubMed ID: 20814402 [Abstract] [Full Text] [Related]
27. [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients]. Nilsson PM. Lakartidningen; 2004 Jul 22; 101(30-31):2426-7. PubMed ID: 15314941 [No Abstract] [Full Text] [Related]
28. Additional benefits of RAS blockade in the treatment of black hypertensives using valsartan/hydrochlorothiazide combination. Cardiovasc J S Afr; 2005 Jul 22; 16(5):285. PubMed ID: 16307164 [No Abstract] [Full Text] [Related]
30. Randomized, double-blinded trial evaluation of valsartan/hydrochlorothiazide combination therapy in mild to moderate essential hypertension in north-east China. Mualin I. J Int Med Res; 2009 Jul 22; 37(1):277. PubMed ID: 19215702 [No Abstract] [Full Text] [Related]
31. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F. Clin Ther; 2004 Sep 22; 26(9):1436-45. PubMed ID: 15531006 [Abstract] [Full Text] [Related]
32. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?]. Zidek W. MMW Fortschr Med; 2004 Jul 08; 146(27-28):41. PubMed ID: 15526662 [No Abstract] [Full Text] [Related]
33. Valsartan plus hydrochlorothiazide for first-line therapy in hypertension. Lacourcière Y, Poirier L, Samuel R. Expert Rev Cardiovasc Ther; 2009 Dec 08; 7(12):1491-501. PubMed ID: 19954310 [Abstract] [Full Text] [Related]
36. [Control of systolic blood pressure in the VALUE trial after 12 months]. Schmieder RE, Handrock R, VALUE-Studienärzte. Dtsch Med Wochenschr; 2003 Mar 07; 128(10):485-6. PubMed ID: 12627338 [No Abstract] [Full Text] [Related]
38. Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence. Simonyi G, Ferenci T, Alföldi S, Farsang C. J Int Med Res; 2016 Oct 04; 44(5):1087-1091. PubMed ID: 27435392 [Abstract] [Full Text] [Related]
39. [Hypertension: improved therapy adherence after switch to a fixed drug combinations]. MMW Fortschr Med; 2012 Mar 22; 154(5):78-9. PubMed ID: 22624273 [No Abstract] [Full Text] [Related]
40. Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination. Vivencio B. Curr Med Res Opin; 2009 Sep 22; 25(9):2267-8; author reply 2268-9. PubMed ID: 19630488 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]